MYCOPHENOLIC ACID AND METABOLITES

Useful for Monitoring therapy with CellCept to ensure adequate blood
levels and avoid overimmunosuppression. Monitoring is recommended
immediately after transplant up to 3 weeks after therapy is initiated to
evaluate dosing adequacy. Additional monitoring is indicated if the MPA
level is not in the therapeutic range or if a major change in health.